Current Treatment Options in Oncology

Papers
(The TQCC of Current Treatment Options in Oncology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Role of Metastasis-Directed Therapy in Genitourinary Cancers152
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer110
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia84
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies70
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma60
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead55
An Update on Temporal Bone Paragangliomas52
Whole Abdominal Radiotherapy in Bone and Soft Tissue Sarcomas: Indications, Techniques, Clinical Outcomes, and Future Directions51
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes48
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect45
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer42
Approach to Localized Squamous Cell Cancer of the Esophagus40
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine Tumors40
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers38
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?37
Small Cell Lung Cancer—An Update on Chemotherapy Resistance33
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma33
Management of Fatigue in Patients with Advanced Cancer33
Regorafenib for the Treatment of Sarcoma32
The Role of Nursing in the Delivery of Cardio-Oncology32
The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer31
Revolutionizing Breast Cancer Therapeutics: Intersecting Frontiers of Precision Medicine, Nanotechnology, and Drug Delivery Innovations31
Advances in Targeted Therapy for Metastatic Prostate Cancer29
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer29
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities28
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs27
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements27
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia27
Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?26
Recognition and Management of the Long-term Effects of Cranial Radiation25
Steroid Premedication and Monoclonal Antibody Therapy: Should We Reconsider?25
A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue Sarcomas24
Gastric Cancer with Sarcopenia: an Area Worth Focusing On24
Endocrinologic Toxicities of Cancer Therapy: Evolving Challenges and Multidisciplinary Approaches24
Research Progress on Ferroptosis in Multiple Myeloma23
Review of Bone Metastasis in Gynecologic Malignancies: Evaluation and Treatment23
Response Evaluation of Neoadjuvant Therapies in Sarcoma22
R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond22
Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis22
Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy21
Novel Estrogen Receptor-Targeted Agents for Breast Cancer21
Dyadic Interventions for LGBTQ+ Individuals Facing Cancer: A Narrative Review21
New Therapeutic Targets in RAS Wild-type Pancreatic Cancer21
Transforming a Roadblock into a Roadmap: Evolving HFSR Management From Adverse Event to Efficacy Biomarker20
Therapeutic Challenges in the Management of Serous Endometrial Intraepithelial Carcinoma (SEIC)20
Contemporary Review of Adenocarcinoma of the Cervix20
Treatment Options for Brain Metastases20
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors20
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities20
Advancing Bladder Cancer Management: The Role of Neoadjuvant and Adjuvant Therapies and Biomarkers in Muscle Invasive Bladder Cancer19
Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer19
Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers19
Perioperative Immune Checkpoint Inhibitors for the Treatment of Locally Advanced Gastric and Gastroesophageal Junction Cancer: Current Status and Future Prospects19
One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract19
Understanding, Recognizing, and Managing Cancer-Related Fatigue Associated with Breast Cancer18
Progress in the Treatment of Small Intestine Cancer18
Updates in Management of Malignant Pleural Mesothelioma18
New Developments in Systemic Management for High-Risk Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer18
What are the Optimal Systemic Treatment Options for Rhabdomyosarcoma?18
New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease18
Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives17
Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma17
How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia17
Navigating PARP Inhibitor Resistance in Ovarian Cancer: Bridging Mechanistic Insights To Clinical Translation17
The Dilemma of Treating Delirium: the Conundrum of Drug Management17
Updates in Breast Cancer Screening and Diagnosis17
Advances in PSMA-Targeted Radionuclide Therapeutics16
Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations16
Myxoid Liposarcomas: Systemic Treatment Options16
The Role of Induction Therapy for Sinonasal Cancers16
Targeting the Renin–angiotensin–aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review15
A Review on Integrating Breast Cancer Clinical Data: A Unified Platform Perspective15
Hypnosis for Symptom Management in Adult Cancer Patients: What is the Evidence?15
“When Less is More”: Paradigm Shifts in Radiation Treatment for Early-Stage Breast Cancer15
Correction to: Cardiotoxicity of Systemic Melanoma Treatments15
New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer14
Re-thinking the Role of Thoracic Radiotherapy in the First-Line Treatment for Extensive-Stage Small Cell Lung Cancer14
Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy14
The Role of SIRT1 in Leukemia14
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus14
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management14
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance14
Taxane-Associated Acute Pain Syndrome: a Review of its Features and Management14
Correction to: Recent Advances in Succinate Dehydrogenase Deficient Gastrointestinal Stromal Tumor Systemic Therapies14
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?14
HER2-Positive Metastatic Colorectal Cancer13
Advancements in Melanoma Therapies: From Surgery to Immunotherapy13
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care?13
Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches13
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming13
Systemic Management of Advanced Adrenocortical Carcinoma12
Therapeutic Management of Malignant Wounds: An Update12
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation12
Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic12
Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer12
Management of Functional Pancreatic Neuroendocrine Neoplasms12
Dermatofibrosarcoma Protuberans (DFSP): Diagnostics and Molecular Pathology12
Targeted Therapy in Early Stage Non-small Cell Lung Cancer12
Osteogenic Sarcoma of the Head and Neck: Is Chemotherapy Needed?12
Systemic Therapy for Salivary Gland Cancers: A Review of Targeted and Chemotherapeutic Approaches12
Extent of Resection and Outcomes of Patients with Primary Malignant Brain Tumors12
Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions12
1.0160579681396